- Relationship to Diabetes
- Type 1
- Pronouns
- He/Him
Published today for England and Wales
For adults with T1 diabetes
Including the section we have already been discussing about widening the access for people with T1 to both Libre 1 & 2 (isCGM - intermittently scanned CGM), and Dexcom / Medtronic / Libre 3 / Medtrum (rtCGM - Realtime CGM)
Additionally guidance for T2 had also been updated:
For adults with type 2 diabetes:
Offer intermittently scanned continuous glucose monitoring (isCGM, commonly referred to as ‘flash’) to adults with type 2 diabetes on multiple daily insulin injections if any of the following apply:
• they have recurrent hypoglycaemia or severe hypoglycaemia
• they have impaired hypoglycaemia awareness
• they have a condition or disability (including a learning disability or cognitive impairment) that means they cannot self-monitor their blood glucose by capillary blood glucose monitoring but could use an isCGM device (or have it scanned for them)
• they would otherwise be advised to self-measure at least 8 times a day.
Link: Type 2 diabetes in adults: management – glucose monitoring
Previous NICE guidelines only recommended CGM to people with type 1 diabetes in very limited circumstances and did not recommend Flash at all. Further, this is the first time NICE has ever recommended Flash use for anyone with type 2 diabetes. That’s why these new guidelines represent such a significant and exciting change.
It is expected that any rollout of recommendations in these guidelines for improved CGM access will take time, and access to varying tech will still be an individual clinical decision, and be subject to relevant criteria.
It’s gonna take some time!!
For adults with T1 diabetes
Including the section we have already been discussing about widening the access for people with T1 to both Libre 1 & 2 (isCGM - intermittently scanned CGM), and Dexcom / Medtronic / Libre 3 / Medtrum (rtCGM - Realtime CGM)
Additionally guidance for T2 had also been updated:
For adults with type 2 diabetes:
Offer intermittently scanned continuous glucose monitoring (isCGM, commonly referred to as ‘flash’) to adults with type 2 diabetes on multiple daily insulin injections if any of the following apply:
• they have recurrent hypoglycaemia or severe hypoglycaemia
• they have impaired hypoglycaemia awareness
• they have a condition or disability (including a learning disability or cognitive impairment) that means they cannot self-monitor their blood glucose by capillary blood glucose monitoring but could use an isCGM device (or have it scanned for them)
• they would otherwise be advised to self-measure at least 8 times a day.
Link: Type 2 diabetes in adults: management – glucose monitoring
Previous NICE guidelines only recommended CGM to people with type 1 diabetes in very limited circumstances and did not recommend Flash at all. Further, this is the first time NICE has ever recommended Flash use for anyone with type 2 diabetes. That’s why these new guidelines represent such a significant and exciting change.
It is expected that any rollout of recommendations in these guidelines for improved CGM access will take time, and access to varying tech will still be an individual clinical decision, and be subject to relevant criteria.
It’s gonna take some time!!
Last edited: